Serial Number | 85545319 |
Word Mark | IMMUNOSEQ |
Filing Date | Thursday, February 16, 2012 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, November 17, 2023 |
Registration Number | 4330339 |
Registration Date | Tuesday, May 7, 2013 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, February 19, 2013 |
Description of Mark | The mark consists of the word "immunoSEQ" with the wording "immuno" in lower case, the wording "SEQ" in uppercase, and the "Q" in "SEQ" appears as a magnifying glass with a glint/reflection mark inside the "Q". |
Amendment to a Registration/Renewal Certificate | The drawing is amended to appear as follows: PUBLISH NEW CUT. In the statement, lines 22 through 26 are deleted, and "The mark consists of the word "immunoSEQ" with the wording "immuno" in lower case, the wording "SEQ" in uppercase, and the "Q" in "SEQ" appears as a magnifying glass with a glint/reflection mark inside the "Q"" is inserted. |
Pseudo Mark | IMMUNO SEQ |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Development of new technology for others in the field of biotechnology; DNA analysis services; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research in the field of genetics and genetic engineering |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, November 17, 2023 |
Primary Code | 042 |
First Use Anywhere Date | Tuesday, September 8, 2009 |
First Use In Commerce Date | Tuesday, September 8, 2009 |
Party Name | Adaptive Biotechnologies Corporation |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98102 |
Party Name | Adaptive Biotechnologies Corporation |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98103 |
Party Name | Adaptive Biotechnologies Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Seattle, WA 98103 |
Event Date | Event Description |
Friday, November 17, 2023 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
Saturday, May 7, 2022 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Wednesday, June 5, 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Wednesday, June 5, 2019 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Wednesday, June 5, 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Tuesday, April 23, 2019 | TEAS SECTION 8 & 15 RECEIVED |
Monday, May 7, 2018 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Tuesday, February 13, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, June 5, 2015 | AMENDMENT UNDER SECTION 7 ¿ PROCESSED |
Monday, June 1, 2015 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Wednesday, May 20, 2015 | TEAS SECTION 7 REQUEST RECEIVED |
Thursday, August 28, 2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, August 28, 2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, May 7, 2013 | REGISTERED-PRINCIPAL REGISTER |
Wednesday, February 20, 2013 | NOTICE OF PUBLICATION |
Tuesday, February 19, 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 19, 2013 | PUBLISHED FOR OPPOSITION |
Wednesday, January 30, 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, January 15, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Tuesday, January 15, 2013 | ASSIGNED TO LIE |
Wednesday, January 2, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, January 2, 2013 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, January 2, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, January 2, 2013 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, January 2, 2013 | EXAMINERS AMENDMENT -WRITTEN |
Monday, June 4, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 4, 2012 | NON-FINAL ACTION E-MAILED |
Monday, June 4, 2012 | NON-FINAL ACTION WRITTEN |
Tuesday, May 29, 2012 | ASSIGNED TO EXAMINER |
Saturday, February 25, 2012 | NOTICE OF DESIGN SEARCH CODE MAILED |
Friday, February 24, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, February 20, 2012 | NEW APPLICATION ENTERED |